Jacob Sullum | April 5, 2006
It's been almost a year since a federal judge in Utah ruled that the FDA's ephedra ban did not have a sound legal basis. Although she enjoined the FDA from taking enforcement action against Nutraceutical, the company that brought the case, for selling dietary supplements containing a daily ephedrine dose of 10 milligrams or less, Nutraceutical has not resumed sales of such products. But a few other companies have, including World Class Nutrition, which last month announced a new line of ephedra-containing supplements: Powerdrine, Ripped Mahuang, and Metabo Mahuang. "These products are going to take the over the counter diet pill industry by storm," the company predicted, adding, "A spokesman for WCN suggests taking advantage of the availability of the weight loss pills while they are available."
As that sales tactic suggests, the ultimate legal status of ephedra is still up in the air. Instead of writing a new ephedra rule that complies with the Nutraceutical ruling, the FDA has appealed the decision. There does not appear to be any mention of the case on the agency's Web site, where a search on "ephedra" turns up nothing more recent than the February 2004 imposition of the ban. Maybe the FDA was hoping it could ignore its defeat and no one would notice.
Help Reason celebrate its next 40 years. Donate Now!
Try Reason's award-winning print edition today! Your first issue is FREE if you are not completely satisfied.
Maybe the FDA was hoping it could ignore its defeat and no
one would notice
I noticed, and I made sure many other people did as well.
Did anyone else catch the "The Meth
Epidemic" on Frontline last night? ...it may have been a rerun.
If I'd had to guess, I would have guessed it was produced by the
DEA.
It made some claims about how they won the War on Quaaludes (which
I'd be interested to see confirmed), and it suggested that they
were trying the same thing with meth. ...but it seemed to infer
(perhaps unintentionally) that regulation of ephedrine
manufacturers, enforcement of those regulations and carding
consumers is effective in combating meth usage rates--more so than
criminalizing use. ...I don't know whether that's true or not, but
that approach seems preferable to me in the same way that I'd
rather have subsidies than tarrifs.
Most meth comes in from Mexico. Tracking of the industrial
chemicals used in manufacturing meth would be the most effective
enforcment tool to fight domestic meth production (hint: don't tell
the meth makers you are tracking it mr DEA man).
And of course legalization would dry up the profit motive
entirely.
It's all about big bribery by big pharma to protect their monopoly
on dangerous, ineffective, prescription diet drugs.
Um, ephedrine is no longer over-the-counter. The law that will make us all sign a log whenever we buy cough medecine (the Combat Meth Act, just passed as part of the PATRIOT reauthorization) regulate pseudoephedrine and its optical isomers (i.e. ephedrine)
Meanwhile on VIOXX, the courts are doing things the FDA should have done if the FDA wasn't such a putz.
Site comments/questions:
Media Inquiries and Reprint Permissions:
(310) 367-6109
Editorial & Production Offices:
3415 S. Sepulveda Blvd.
Suite 400
Los Angeles, CA 90034
(310) 391-2245